Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.63
+0.03 (0.54%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2018 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '18 2016 - 2018
Gene and Cell Therapies
3.50M
Log In
Log In
Log In
Log In
Upgrade
Gene and Cell Therapies Growth
147.52%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2018 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '18 2016 - 2018
United States
3.50M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
147.52%
Log In
Log In
Log In
Log In
Upgrade